health
A revolutionary cancer treatment could transform autoimmune disease
Researchers are testing CAR T cell therapy as a way to reset the immune system.
TL;DR
- CAR T cell therapy reprograms a patient's immune T cells to target and eliminate specific cells, initially for cancer treatment.
- The therapy is now being explored for autoimmune diseases like multiple sclerosis and lupus, aiming to reset the immune system by targeting self-destructive B cells.
- Early trials show positive results, with patients experiencing symptom improvement and reduced reliance on other treatments.
- Potential risks include severe inflammation, decreased immunity, and theoretical long-term side effects such as secondary cancers, though these are becoming better understood and managed.
- High costs and the complexity of personalized cell engineering are significant barriers, leading to research into 'off-the-shelf' donor cell and in-vivo modification approaches.
- Jan Janisch-Hanzlik, an early participant in a CAR T trial for multiple sclerosis, experienced significant symptom improvement.